BBLG
What one share of Bone Biologics holds
Orthopedic, Prosthetic and Surgical Appliances and Supplies
Bone Biologics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$1.61 |
|---|---|
| Cash and investments | $2.23 |
| Book value | $2.17 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2023 | — | −$204.05 | — | — | — | — |
| 2024 | — | −$28.96 | — | — | — | $7.07 |
| 2025 | — | −$2.65 | — | — | — | $3.00 |
Common questions about Bone Biologics
How much does one share of Bone Biologics earn?
Over the last 12 months, Bone Biologics lost $1.61 for each share.
Does Bone Biologics pay a dividend?
Bone Biologics didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Bone Biologics’s book value per share?
Bone Biologics’s book value is $2.17 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Bone Biologics have?
Each share of Bone Biologics has $2.23 of cash and investments, as of June 30, 2026.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.